Control Signal Storage (e.g., Programming) Patents (Class 607/59)
-
Patent number: 12642475Abstract: Systems and methods are disclosed for conducting spinal cord stimulation or other neurostimulation and sensing evoked compound action potential (ECAP) signals. The sensed signals may be processed to isolate ECAP features from noise and/or interfering signals. The isolated ECAP features may be used to control neurostimulation therapy for the patient, such as to quantify or measure lead migration and adjust a neurostimulation therapy for the patient to account for an impact of any detected lead migration, or other purposes (e.g., to guide an implant procedure).Type: GrantFiled: July 12, 2023Date of Patent: June 2, 2026Assignee: Advanced Neuromodulation Systems, Inc.Inventors: Mingming Zhang, Hyun-Joo Park, Erika Ross, Ameya Nanivadekar, Nishant Verma
-
Patent number: 12629504Abstract: Provided is a needle assembly including: a plurality of needles; a main body having a plurality of holes through which the plurality of needles pass in a first direction; and a fixing member coupled to the main body and having a plurality of fixed inclined surfaces supporting the plurality of needles.Type: GrantFiled: May 22, 2020Date of Patent: May 19, 2026Assignee: SERENDIA, LLCInventors: Jongju Na, Heeyoung Lee, Dongkeun Shin
-
Patent number: 12605552Abstract: Devices, systems, and techniques are configured for independently modulating two or more concurrent signals of electrical stimulation therapy. In one example, a system includes stimulation generation circuitry and processing circuitry configured to control the stimulation generation circuitry to deliver first electrical stimulation to a patient via a first electrode combination, wherein the first electrical stimulation is defined by at least a first set of stimulation parameters selected that the first electrical stimulation exceeds a first perception threshold, and control the stimulation generation circuitry to deliver second electrical stimulation, concurrent with the first electrical stimulation, to the patient via a second electrode combination. The second electrical stimulation may be defined by at least a second set of stimulation parameters selected that the second electrical stimulation is below a second perception threshold.Type: GrantFiled: February 22, 2022Date of Patent: April 21, 2026Assignee: Medtronic, Inc.Inventors: David A. Dinsmoor, Leonid M. Litvak, Jeffery M. Kramer
-
Patent number: 12605557Abstract: An automated external defibrillator includes: an operation accepter that accepts an operation input from a user; and a self-test executor that executes a self-test for checking a state of the automated external defibrillator when a first condition or a second condition has been satisfied. The first condition is that a setting time instant set in advance comes. The second condition is that the operation accepter accepts a predetermined operation input.Type: GrantFiled: June 2, 2021Date of Patent: April 21, 2026Assignee: Nihon Kohden CorporationInventors: Ryosuke Kuno, Kanchi Ito, Yuji Igawa, Fumihito Iwai, Tsutomu Wakabayashi
-
Patent number: 12569684Abstract: Methods and circuitry for calibrating stimulation circuitry in an implantable stimulator device (ISD) is disclosed. The ISD can sense neural response to the stimulation, and use an algorithm to assess those responses and determine a therapeutic window for a particular stimulation parameter, such as amplitude. Stimulation circuitry in the ISD is programmed with information indicative of the determined therapeutic window, such as by programming a minimum and/or maximum current amplitude. As well as restricting operation of the stimulation circuitry to within the therapeutic amplitude window, such programming calibrates the stimulation circuitry and allows an expanded range of, or all of, amplitude values supported by the stimulation circuitry to be used, which allows the amplitude to be incremented in smaller current increments.Type: GrantFiled: September 16, 2022Date of Patent: March 10, 2026Assignee: Boston Scientific Neuromodulation CorporationInventors: Pujitha Weerakoon, Kiran K. Gururaj, Goran N. Marnfeldt
-
Patent number: 12567484Abstract: A data system for managing information associated with an implantable device includes the implantable device. The data system is configured as a distributed database to store the information in two or more nodes of the data system. The implantable device is configured as one of the two or more nodes. The information includes at least one information entity. The at least one information entity includes at least one of the following: a patient identifiable information, a follow-up information, an implantable device information, or a lead system information.Type: GrantFiled: August 9, 2022Date of Patent: March 3, 2026Assignee: BIOTRONIK SE & Co. KGInventors: James Horton, Dean Bergstrom, Rainer Joerg Grosskopf, Dirk Kleeblatt, Thorsten Wenzlaff
-
Patent number: 12567495Abstract: Methods and systems for planning a trajectory for implanting electrical stimulation leads in a patient's brain are described. The methods and systems rank candidate trajectories based on their expected therapeutic efficacies, as well as other criteria. Optimized stimulation parameters are determined for each of the candidate trajectories and therapeutic efficacies using the optimized parameters are predicted.Type: GrantFiled: October 17, 2023Date of Patent: March 3, 2026Assignee: Boston Scientific Neuromodulation CorporationInventors: Mahsa Malekmohammadi, Lisa Moore, G. Karl Steinke, Raul Serrano Carmona
-
Patent number: 12558551Abstract: Disclosed herein are systems and methods that can involve a neuromodulation device configured to perform in multiple electrical modulation modes with a single architecture.Type: GrantFiled: June 29, 2023Date of Patent: February 24, 2026Assignee: Presidio Medical, Inc.Inventors: Michael A. Faltys, Aaron Hardinger, James Harris, Douglas Michael Ackermann, Kenneth S. Wu
-
Patent number: 12556955Abstract: A measurement indication method includes: obtaining at least one of first information, second information, or third information. The first information is related to a granularity of the terminal performing a non-connected state measurement; the second information is related to a granularity of the terminal reporting validity of a non-connected state measurement result; the third information is related to a granularity of the terminal reporting the non-connected state measurement result; and the granularity is related to at least one of a reference signal, a measurement quantity, or a frequency banks.Type: GrantFiled: December 22, 2022Date of Patent: February 17, 2026Assignee: VIVO MOBILE COMMUNICATION CO., LTD.Inventors: Wenjuan Pu, Xiaodong Yang, Xuanbing Liu
-
Patent number: 12544574Abstract: Systems and methods for controlling autonomic symptoms or side effects via spinal cord stimulation are discussed. An exemplary neuromodulation system comprises an electrostimulator to provide spinal cord stimulation (SCS) to a neural target, a user interface device to receive a user input including an autonomic symptom and affected anatomy, and a controller circuit to determine or adjust a stimulation parameter based at least on the autonomic symptoms and the affected anatomy. Spinal cord stimulation can be delivered in accordance with the determined or adjusted stimulation parameter to alleviate the autonomic symptom, or to treat or alleviate autonomic disorders.Type: GrantFiled: May 8, 2023Date of Patent: February 10, 2026Assignee: Boston Scientific Neuromodulation CorporationInventors: Ismael Huertas Fernandez, Que T. Doan
-
Patent number: 12539424Abstract: A stimulation engine configured to identify a fault condition in an implantable lead, including a regulator configured to deliver an electrical pulse between at least two electrodes of the implantable stimulation lead, and a sensing module configured to detect at least an initial voltage and a subsequent voltage between the at least two electrodes at different times during delivery of the electrical pulse, and compare at least the subsequent voltage to a defined threshold value representing an expected voltage at the same time during the electrical pulse to determine the presence of a fault condition.Type: GrantFiled: February 23, 2022Date of Patent: February 3, 2026Assignee: Medtronic, Inc.Inventors: Timothy R. Abraham, Nathan A. Torgerson, Scott R. Stanslaski
-
Patent number: 12533517Abstract: A medical apparatus for a patient comprises an implantable system. The implantable system comprises a first implantable device comprising: at least one implantable functional element configured to deliver stimulation energy to tissue of the patient; and an implantable controller configured to provide a stimulation waveform to the at least one implantable functional element, the stimulation waveform comprising one or more stimulation parameters. The apparatus is configured to randomly vary at least one of the one or more stimulation parameters. Methods of providing stimulation energy with randomly varying stimulation parameters are also provided.Type: GrantFiled: July 9, 2021Date of Patent: January 27, 2026Assignee: Nalu Medical, Inc.Inventors: Lakshmi Narayan Mishra, James C. Makous, Lee Fason Hartley, Daniel M. Pivonka, J. Christopher Flaherty
-
Patent number: 12533511Abstract: Provided is a monopolar skin treatment apparatus using electrical energy in a high frequency wavelength band in which a retaining ligament, a blood vessel, and a fibrous tissue of a deep part is utilized as an electricity passage to actively prevent the skin from sagging due to the aging.Type: GrantFiled: February 27, 2023Date of Patent: January 27, 2026Assignee: JEISYS MEDICAL INC.Inventors: Suk Bae Seo, Ja Young Kim, Ho Joon Seo
-
Patent number: 12533518Abstract: A method of controlling a neural stimulus, the neural stimulus being defined by at least one stimulus intensity parameter. The method comprises, generating a stimulus intensity parameter to control a stimulator that generates a stimulus current for application to a tissue, measuring a response of the tissue, evoked by the stimulus current, determining a response parameter indicative of the measured response, in response to the response parameter being less than a first threshold, setting the stimulus intensity parameter to a desired stimulus intensity level; and in response to the response parameter being greater than a second threshold, adjust the stimulus intensity parameter according to a feedback variable derived from the measured response.Type: GrantFiled: August 27, 2021Date of Patent: January 27, 2026Assignee: Saluda Medical Pty LtdInventors: Peter Scott Vallack Single, Joanne Carol Shiels Olecko, Robert Bruce Gorman, James Hamilton Wah
-
Patent number: 12527497Abstract: A continuous glucose monitoring (CGM) system is configured to detect a reinserted CGM sensor. The system reads a CGM sensor identifier stored in a CGM sensor unit memory in response to insertion of a CGM sensor into the skin of user. The system compares the identifier to any previously-stored identifiers of previously-inserted CGM sensors. If the identifier does not match a previously-stored identifier, indicating a newly-inserted sensor, the identifier is stored and CGM may begin. If the identifier matches a previously-stored identifier, indicating a reinserted sensor, a usage limit corresponding to the stored identifier of the reinserted sensor is then checked to determine whether it has been met. If it has, CGM is halted. If it has not, CGM may continue with the reinserted CGM sensor. Methods of detecting reinsertion and usage limits of a CGM sensor are also provided, as are other aspects.Type: GrantFiled: July 13, 2021Date of Patent: January 20, 2026Assignee: Ascensia Diabetes Care Holdings AGInventor: Anthony P. Russo
-
Patent number: 12521547Abstract: An arrhythmia treatment device, the device may comprise: a first electrode configured to output a stimulus corresponding to input treatment conditions to electrically stimulate nerves of a user on the basis of the input treatment conditions; a second electrode configured to measure biosignals of the user for a predetermined time interval after the first electrode outputs the stimulus; and a controller configured to check an arrhythmia treatment result of the user on the basis of the biosignals measured for the predetermined time interval, and to control output of the first electrode based on the checked arrhythmia treatment result.Type: GrantFiled: May 30, 2023Date of Patent: January 13, 2026Assignees: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITYInventors: Yunseo Ku, Hee Chan Kim, Seil Oh, Jang Jay Sohn
-
Patent number: 12485281Abstract: Restless Leg Syndrome (RLS) or Periodic Limb Movement Disorder (PLMD) can be treated using high frequency (HF) electrostimulation. This can include selecting or receiving a subject presenting with RLS or PLMD. At least one electrostimulation electrode can be located at a location associated with at least one of, or at least one branch of, a sural nerve, a peroneal nerve, or a femoral nerve. HF electrostimulation can be delivered to the subject, which can include delivering subsensory, subthreshold, AC electrostimulation at a frequency that exceeds 500 Hz and is less than 15,000 Hz to the location to help reduce or alleviate the one or more symptoms associated with RLS or PLMD. A charge-balanced controlled-current HF electrostimulation waveform can be used.Type: GrantFiled: November 30, 2023Date of Patent: December 2, 2025Assignee: NOCTRIX HEALTH, INC.Inventor: Shriram Raghunathan
-
Patent number: 12485284Abstract: Systems and methods for customizable titration of an implantable neurostimulator are provided. A method of titrating a neurostimulation signal delivered to a patient from an implantable pulse generator includes delivering a first neurostimulation signal with a first set of parameters, increasing a first value of the first neurostimulation signal at a first rate for a first period of time while delivering the first neurostimulation signal, ceasing delivery of the first neurostimulation signal when the first value reaches a first target value, delivering a second neurostimulation signal with a second set of parameters, and increasing the second neurostimulation signal at a second rate for a second period of time while delivering the second neurostimulation signal.Type: GrantFiled: June 3, 2024Date of Patent: December 2, 2025Assignee: LivaNova USA, Inc.Inventors: Scott Stubbs, Imad Libbus, Scott Mazar, Bruce KenKnight, Badri Amurthur
-
Patent number: 12472349Abstract: An implantable device is configured to control application of a neural stimulus as defined by a stimulus parameter; measure via the measurement circuitry a characteristic of a neural compound action potential response evoked by the stimulus; and compute, using the stimulus parameter and the measured characteristic of the evoked neural compound action potential response, a characteristic of an evoked response that would be obtained from the neural stimulus if the patient were in a reference posture. A posture of the patient can be estimated from the computed characteristic and/or the computed characteristic can be used as a feedback variable of a feedback loop. Multidimensional histograms of datasets comprising at least one of the stimulus parameter and a feedback variable can be stored.Type: GrantFiled: August 30, 2021Date of Patent: November 18, 2025Assignee: Saluda Medical Pty LtdInventors: James Hamilton Wah, Amol Malla
-
Patent number: 12427315Abstract: An example of a neurostimulation system may include a programming control circuit and a stimulation control circuit. The programming control circuit may be configured to program a stimulation device for delivering the neurostimulation according to a stimulation program specifying a present stimulation field set including stimulation field(s) each defined by a set of active electrodes selected from a plurality of electrodes. The stimulation control circuit may be configured to determine the stimulation program and may include field programming circuitry that may be configured to set the present stimulation field set to an initial stimulation field set specifying stimulation fields allowing for the delivery of the neurostimulation to produce an intended effect and to identify an optimal stimulation field set that satisfies one or more optimization criteria by removing stimulation field(s) from the initial stimulation field set.Type: GrantFiled: May 10, 2023Date of Patent: September 30, 2025Assignee: Boston Scientific Neuromodulation CorporationInventors: Michael A. Moffitt, Rafael Carbunaru
-
Patent number: 12415079Abstract: A neuromodulation system including at least one input module for inputting a planned neuromodulation event or a series of neuromodulation events and at least one analyzing module for analyzing a neuromodulation event or a series of neuromodulation events. The analyzing module and the input module may be connected such that the input module is configured to forward the planned neuromodulation event or a series of neuromodulation events to the analyzing module and the analyzing module is configured to analyze the planned neuromodulation event or a series of neuromodulation events regarding one or more possible neuromodulation conflict(s).Type: GrantFiled: August 29, 2022Date of Patent: September 16, 2025Assignee: Onward Medical N.V.Inventors: Mathieu Scheltienne, Jeroen Tol, Robin Brouns
-
Patent number: 12402004Abstract: An external device for wireless communication with an implantable medical device can include a memory having stored thereon instructions for a first application and authentication credentials specific to the first application; and a processor configured for transmitting the authentication credentials specific to the first application to an implantable medical device to authorize access to the implantable medical device by the first application.Type: GrantFiled: October 28, 2021Date of Patent: August 26, 2025Assignee: Boston Scient ation CorporationInventors: Sridhar Kothandaraman, Berj Doudian, Chirag Shah, Joshua Uyeda, Keron Greene
-
Patent number: 12383305Abstract: Subcutaneous implantation tools and methods of implanting a subcutaneous device using the same. The tool may include a tool body having a longitudinally extending recess having a distal opening and having a tunneler at a distal end of the tool body extending from the distal opening of the recess. The tool may include a plunger slidably fitting within at least a portion of the tool body recess. The recess may be configured to receive an implantable device and the tunneler preferably extends distally from the recess at a position laterally displaced from the device when the device is so located in the recess. Movement of the plunger distally within the recess advances the device distally out of the recess and alongside of and exterior to the tunneler.Type: GrantFiled: October 6, 2023Date of Patent: August 12, 2025Assignee: Medtronic, Inc.Inventors: Matthew T. Vanderpool, Michael R. Klardie, Kris A. Peterson
-
Patent number: 12383761Abstract: Disclosed is a body-wearable apparatus for treating pain by a principle of complex photo-biochemical actions.Type: GrantFiled: January 27, 2021Date of Patent: August 12, 2025Assignee: Wellscare Co., LtdInventors: Sang-Hyun Chang, Sung-Won Lee
-
Patent number: 12377260Abstract: Vagal nerve stimulation devices and methods are provided herein. A device comprises one or more electrodes having a contact surface for contacting an outer skin surface of a patient and an energy source coupled to the electrodes. The energy source generates one or more electrical impulses and transmits the electrical impulses to the electrodes and transcutaneously through the outer skin surface of the patient at or near a vagus nerve. The one or more electrical pulses comprise bursts of 2 to 20 pulses within each burst with each burst having a frequency of about 5 Hz to about 100 Hz.Type: GrantFiled: July 22, 2024Date of Patent: August 5, 2025Assignee: Electrocord, Inc.Inventors: Bruce J. Simon, Joseph P. Errico, John T. Raffle
-
Patent number: 12364860Abstract: Method and system for altering body mass composition in a human subject repeatedly apply galvanic vestibular stimulation (GVS) to the subject's scalp at a location corresponding to each of the subject's left and right vestibular systems. The methods may be used to treat obesity-related diseases such as diabetes, hypertension, type 2 diabetes mellitus and osteoporosis.Type: GrantFiled: January 26, 2024Date of Patent: July 22, 2025Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventors: Paul Duncan McGeoch, Vilayanur S. Ramachandran
-
Patent number: 12354741Abstract: A medical device, such as a neurostimulator, is provided that includes a housing, a power supply, a signal generator and one or more electrodes coupled to the housing. The signal generator is configured to apply one or more electrical impulses to the one or more electrodes for a period of time, the period of time being defined as a single dose. The device is configured to switch from an activated mode and a deactivated mode after specific number of single doses have been emitted by the signal generator.Type: GrantFiled: November 15, 2023Date of Patent: July 8, 2025Assignee: ELECTROCORE, INC.Inventors: Joseph P. Errico, Francis R. Amato, Steven M. Mendez, Hecheng Hu
-
Patent number: 12329971Abstract: Disclosed is a method of adapting the operation of an implantable device for delivering neurostimulation therapy to a patient. The method comprises: delivering the neurostimulation therapy to electrically excitable tissue of the patient according to at least one therapy parameter; measuring a physiological characteristic of the patient; adjusting the at least one therapy parameter according to a schedule of adjustment and the measured physiological characteristic; and repeating the delivering, measuring, and adjusting.Type: GrantFiled: July 15, 2022Date of Patent: June 17, 2025Assignee: Saluda Medical Pty LtdInventors: John Louis Parker, Peter Scott Vallack Single, Dean Michael Karantonis, Matthew Marlon Williams, Daniel John Parker, Samuel Nicholas Gilbert
-
Patent number: 12295637Abstract: Systems, devices, and methods for current control of energy delivery to ablate tissue are disclosed. A generator may include a set of electrode channels coupled to a set of electrodes during use. Each electrode channel from the set of electrode channels may include a first switch from a first set of switches and a second switch from a second set of switches. A set of energy sources may be coupled to a third set of switches. The third set of switches may be configured to switch from an OFF state to an ON state to couple the set of energy sources to the set of electrodes. A set of resistors may be coupled to the second set of switches. The second set of switches may be configured to switch from an OFF state to an ON state to couple the set of resistors to the set of electrodes.Type: GrantFiled: August 7, 2020Date of Patent: May 13, 2025Assignee: Boston Scientific Scimed, Inc.Inventor: Raju Viswanathan
-
Patent number: 12285603Abstract: The problem of a potentially high amount of supra-threshold charge passing through the patient's tissue at the end of an Implantable Pulse Generator (IPG) program is addressed by circuitry that periodically dissipates only small amount of the charge stored on capacitances (e.g., DC-blocking capacitors) during a pulsed post-program recovery period. This occurs by periodically activating control signals to turn on passive recovery switches to form a series of discharge pulses each dissipating a sub-threshold amount of charge. Such periodic pulsed dissipation may extend the duration of post-program recovery, but is not likely to be noticeable by the patient when the programming in the IPG changes from a first to a second program. Periodic pulsed dissipation of charge may also be used during a program, such as between stimulation pulses.Type: GrantFiled: January 12, 2023Date of Patent: April 29, 2025Assignee: Boston Scientific Neuromodulation CorporationInventors: Emanuel Feldman, Jordi Parramon, Goran N. Marnfeldt, Adam T. Featherstone
-
Patent number: 12280257Abstract: Systems and methods are disclosed to permit a patient to use his external controller to move the location of stimulation in an implantable stimulator system. The external controller can be programmed with a steering algorithm, which prompts the patient to enter certain data regarding their symptoms (e.g., pain), such as pain scores and stimulation coverage. Such data is preferably entered for a plurality of different regions of the patient's body. The algorithm can compute for each body regions a targeting precision value (TP), and from these values determine a steering vector D that suggests a direction and/or a magnitude that stimulation can be moved in the electrode array to more precisely target the patient's pain. The patient may then move the location of the stimulation in accordance with the steering vector using their external controller. The algorithm can be repeated if necessary to again move the stimulation.Type: GrantFiled: May 16, 2022Date of Patent: April 22, 2025Assignee: Boston Scientific Neuromodulation CorporationInventors: Ismael Huertas Fernandez, Que T. Doan
-
Patent number: 12284102Abstract: Systems and methods for detecting collaboration sessions and other workloads in a heterogeneous computing platform are described. In some embodiments, an Information Handling System (IHS) may include a heterogeneous computing platform having a plurality of devices and a memory coupled to the heterogeneous computing platform, where the memory includes a plurality of sets of firmware instructions, where each set of firmware instructions, upon execution by a respective device, enables the respective device to provide a corresponding firmware service, and where at least one of the plurality of devices operates as an orchestrator configured to collect telemetry from the plurality of devices and detect a collaboration session based, at least in part, upon the telemetry.Type: GrantFiled: September 1, 2022Date of Patent: April 22, 2025Assignee: Dell Products, L.P.Inventors: Daniel L. Hamlin, Srikanth Kondapi, Todd Erick Swierk
-
Patent number: 12274494Abstract: A method of treating tissue of a patient uses a device including a mother case, a belt, at least one treatment unit and at least two applicators. The treatment method may include attaching first and second applicators to the belt at a working distance to the patient's surface, and providing different treatment energy to the first applicator and the second applicator. A treatment pattern is created by the applicators providing the different treatment energies. The hardware pattern or positions of the applicators on the belt may be changed before and/or during the treatment. The hardware pattern may be based on selected treatment effect and body part.Type: GrantFiled: February 7, 2024Date of Patent: April 15, 2025Assignee: BTL Healthcare Technologies A.S.Inventor: Tomás Schwarz
-
Patent number: 12272980Abstract: Representative methods, apparatus and systems are disclosed for providing concurrent electrical stimulation and electrical recording in a human or non-human subject, such as for neuromodulation, with the apparatus coupleable to an electrode array. A representative apparatus is typically an integrated circuit including: stimulation circuits, recording circuits, and blocking circuits responsive to control signals to block the stimulation voltage or current on an electrode from a corresponding recording circuit, while other recording circuits may simultaneously record electrical signals from other electrodes and generate recorded data.Type: GrantFiled: October 14, 2023Date of Patent: April 8, 2025Assignee: Nia Therapeutics, Inc.Inventors: Rikky Muller, Benjamin Johnson, Igor Izyumin
-
Patent number: 12263343Abstract: A method of neurostimulation titration includes titrating a neurostimulation signal from a first set of parameters toward a target set of parameters according to a titration aggressiveness profile having a titration hold point. The method further includes receiving a hold indicator indicating that the titration has reached the titration hold point. The method further includes initiating an intermediate hold of the titrating of the neurostimulation signal in response to receiving the hold indicator. The method further includes receiving an indication of a titration resumption that discontinues the intermediate hold.Type: GrantFiled: August 15, 2023Date of Patent: April 1, 2025Assignee: LivaNova USA, Inc.Inventors: Scott Stubbs, Imad Libbus, Scott Mazar, Bruce H. KenKnight, Badri Amurthur
-
Patent number: 12251563Abstract: A system for controlling delivery of electrical stimulation to a subject. The system comprises a control device configured to send stimulation instructions to an electrical stimulation generator to cause the electrical stimulation generator to deliver transcranial electrical stimulation to one or more electrodes arranged to be positioned in proximity to a targeted region of the brain of the subject. The stimulation instructions comprise stimulation parameter value(s). The control device is configured to receive sensor data from optical sensor(s) arranged to be positioned in proximity to the targeted region and transmit updated stimulation instructions comprising updated simulation parameter value(s) to the electrical stimulation generator to cause the electrical stimulation generator to modify characteristic(s) of the stimulation. The system is configured to analyse the sensor data to determine an activity measure and determine updated stimulation parameter value(s) based on the determined activity measure.Type: GrantFiled: December 22, 2023Date of Patent: March 18, 2025Assignee: Neurode Pty LtdInventors: Nathalie Gouailhardou, Damian Sofrevski
-
Patent number: 12233263Abstract: The present disclosure is directed to a system and method modulating targeted neural and non-neural tissue of a nervous system for the treatment of head-and-face pain. Electrical stimulation is delivered transcutaneously to the treatment site that modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting nervous signaling and the perception of pain.Type: GrantFiled: August 22, 2022Date of Patent: February 25, 2025Assignee: Avent, Inc.Inventors: David M. Page, Eric A. Schepis, Jalpa Shah, Natalia Alexeeva
-
Patent number: 12201835Abstract: A system may include electrodes on at least one lead configured to be operationally positioned for use in modulating a volume of neural tissue, a neural modulation generator configured to deliver energy using at least some electrodes to modulate the volume of neural tissue, a programming system configured to program the programmed modulation parameter set, including determine electrode fractionalizations for the electrodes based on a target multipole. The programmed parameter set may include the determined electrode fractionalizations. The target multipole may be used to determine electrode fractionalizations having at least three target poles that directionally and progressively stack fractionalizations of target poles to provide a linear electric field over the volume of tissue. The neural modulation generator may be configured to use the programmed modulation parameter set to provide the linear electric field over the volume of tissue.Type: GrantFiled: June 8, 2022Date of Patent: January 21, 2025Assignee: Boston Scientific Neuromodulation CorporationInventors: Tianhe Zhang, Que T. Doan
-
Patent number: 12179024Abstract: Methods and systems are described for detecting if a stimulation lead implanted in a patient's brain has moved. Lead movement occurring between a first time and a second time may be determined by comparing features extracted from evoked potentials recorded at the two times. The disclosed methods and systems are particularly useful for determining if a stimulation lead has moved between the time it was implanted in the patient's brain and the time that stimulation parameters are being optimized. Lead movement during implantation, during parameter optimization, and during or between other lead optimization processes may be determined as well.Type: GrantFiled: October 9, 2023Date of Patent: December 31, 2024Assignee: Boston Scientific Neuromodulation CorporationInventors: Rosana Esteller, Mahsa Malekmohammadi, Andrew Haddock, Tianhe Zhang
-
Patent number: 12170150Abstract: Via a graphical interface, virtual representations of an anatomical region of a human and a medical device selection mechanism are displayed. The medical device selection mechanism includes a plurality of implantable leads each medically implantable in the anatomical region. In the graphical interface, a user-selected implantable lead is moved from the medical device selection mechanism to the anatomical region. A first side of the user-selected implantable lead is initially displayed when the user-selected implantable lead is moved to the anatomical region. In the graphical interface, the user-selected implantable lead is automatically rotated in the anatomical region, such that a second side of the user-selected implantable lead is displayed after the user-selected implantable lead has been automatically rotated. The second side is opposite the first side.Type: GrantFiled: April 29, 2022Date of Patent: December 17, 2024Assignee: Cirtec Medical Corp.Inventors: Norbert Kaula, Yohannes Iyassu
-
Patent number: 12150891Abstract: A method of neurostimulation may include delivering an electrical signal to a plurality of electrodes connected to a patient. The electrical signal may include a plurality of spaced-apart packets of electrical pulses. The method may include modulating at least one of a quantity of the plurality of electrical pulses within ones of the plurality of packets of electrical pulses, a width in time of the plurality of electrical pulses within ones of the plurality of packets of electrical pulses, an amplitude in voltage of the plurality of electrical pulses within ones of the plurality of packets of electrical pulses, a separation in time between adjacent ones of the plurality of electrical pulses within ones of the plurality of packets of electrical pulses, and a separation in time between adjacent ones of the plurality of packets of electrical pulses to modulate the electrical signal.Type: GrantFiled: February 9, 2021Date of Patent: November 26, 2024Assignee: SCION NEUROSTIM, INC.Inventors: Robert D. Black, Lanty L. Smith, Lesco L. Rogers
-
Patent number: 12109418Abstract: An example system includes a lead including a first electrode disposed at a first level, a second electrode disposed at a second level, a first group of segmented electrodes disposed at a third level, and a second group of segmented electrodes disposed at a fourth level. The example system also includes a medical device configured to deliver symmetrical electrical stimulation to a patient via the first group of segmented electrodes and the second group of segmented electrodes and sense a response to the stimulation via the first electrode and the second electrode.Type: GrantFiled: November 9, 2021Date of Patent: October 8, 2024Assignee: Medtronic, Inc.Inventors: Brendan J. Young-Dixon, Thomas L Chouinard, Lance Beall
-
Patent number: 12088686Abstract: The present disclosure discusses system and methods for improving the efficiency of a remote computing device. The system and methods include generate a profile and delivery schedule for the remote computing device. The system can dynamically update the delivery schedule of future requests the system transmits to the remote computing device based on responses to current request.Type: GrantFiled: October 16, 2023Date of Patent: September 10, 2024Assignee: Click Therapeutics, IncInventors: Victor Gao, David Klein
-
Patent number: 12083332Abstract: Apparatus and methods for imposing electric fields through a target region in a body of a patient are described. Generally, the apparatus includes at least one transducer array and a connector electrically connected to the at least one transducer array. The connector has at least one indicator electrical connector configured to provide feedback related to a status of the connector.Type: GrantFiled: September 30, 2021Date of Patent: September 10, 2024Assignee: Novocure GmbHInventors: Yoram Wasserman, Stas Obuchovsky, Nataliya Kuplennik
-
Patent number: 12070607Abstract: An example of a system for delivering neurostimulation may include a programming control circuit and a stimulation control circuit. The programming control circuit may be configured to generate stimulation parameters controlling delivery of the neurostimulation according to a stimulation configuration. The stimulation control circuit may be configured to specify the stimulation configuration, and may include volume definition circuitry and stimulation configuration circuitry. The volume definition circuitry may be configured to determine one or more test volumes, determine a clinical effect resulting from the one or more test volumes each being activated by the neurostimulation, and determine a target volume using the determined clinical effect. The stimulation configuration circuitry may be configured to generate the specified stimulation configuration for activating the target volume.Type: GrantFiled: October 27, 2022Date of Patent: August 27, 2024Assignee: Boston Scientific Neuromodulation CorporationInventors: Tianhe Zhang, Michael A. Moffitt, Richard Mustakos, Stephen Carcieri
-
Patent number: 12057221Abstract: The present invention relates to the field of medical devices and discloses a program control system and method for an implantable electronic device. The program control system includes at least one communication device, at least one terminal device and a cloud server communicatively connected to both the communication device and the terminal device. The communication device is configured to acquire feedback data from the implantable electronic device (IED) and upload the feedback data to the cloud server. The cloud server is configured to process the feedback data and store the processed feedback data. The terminal device is configured to retrieve the processed feedback data from the cloud server for enquiry by a user. In the present invention, there is also provided a program control method for an implantable electronic device.Type: GrantFiled: March 12, 2019Date of Patent: August 6, 2024Assignee: MICROPORT SOARING CRM (SHANGHAI) CO., LTD.Inventor: Li Wang
-
Patent number: 12040077Abstract: Systems and methods are provided for determining the placement of energy-delivery nodes of an energy-based therapeutic device. In one aspect, recommended placement locations are customized by analyzing an image or video of the user and may be superimposed on an image corresponding to an affected body part.Type: GrantFiled: March 28, 2022Date of Patent: July 16, 2024Assignee: DJO, LLCInventor: Pierre-Yves Lampo
-
Patent number: 12036179Abstract: A handheld system of automatic acupoint stimulation has a case, a camera unit, a storage unit, a human-machine-interface (HMI) unit, a processing unit, an acupoint recognizing unit, and an acupoint stimulating unit. The case has an accommodating space and a handle portion. The camera unit is to capture an image from a body part of a user. The storage unit is to store multiple predetermined acupoint data. The HMI unit is to receive an input signal. The processing unit searches for at least one predetermined acupoint datum that is corresponding to the input signal. The acupoint recognizing unit is to receive the at least one predetermined acupoint datum and obtain a reference length and a beginning basis to locate the acupoint. The acupoint stimulating unit is to stimulate the acupoint of the user located by the acupoint recognizing unit.Type: GrantFiled: December 4, 2020Date of Patent: July 16, 2024Assignee: FENG CHIA UNIVERSITYInventors: Yu-Chen Lin, Jui-Yu Chen, Shuan-You Lin, Ching-Kun Chen
-
Patent number: 12005250Abstract: Incorrect connection or mapping of leads' proximal terminals to the ports of an Implantable Stimulator Device (ISD), such as an implantable pulse generator or an external trial stimulator, is a concern, and this disclosure is directed to use of measurement and identification algorithms to either determine that leads are properly connected to their assigned ISD ports, or to determine which leads are connected to the ports even if the leads are not preassigned to the ports. Particular focus is given in the disclosed technique to assessing leads that comprise larger number of electrodes than are supported at each port, and thus have more than one proximal terminal that connect to more than one port of the ISD.Type: GrantFiled: July 28, 2021Date of Patent: June 11, 2024Assignee: Boston Scientific Neuromodulation CorporationInventors: Kelsey Bower, G. Karl Steinke, Hemant Bokil, Ara Sarian
-
Patent number: 11998742Abstract: The present disclosure provides systems and methods for treating a virus disease in a subject in need thereof.Type: GrantFiled: August 16, 2023Date of Patent: June 4, 2024Inventors: Seung Eun Choi, Yong Sun Lee, Ja Rang Hahm